(Press-News.org) The use of an intensified form of radiotherapy in patients with locally advanced head and neck cancers can improve overall survival rates compared with standard radiation therapy, according to results from a large study to be presented today (Saturday) at the 2013 European Cancer Congress (ECC2013) [1].
A comparison of altered fractionation radiotherapy (AFRT) with standard fractionation radiotherapy (SFRT) in a meta-analysis of more than 11,000 patients showed an eight percent reduction in the risk of death in the AFRT group, as well as a nine percent reduction in the risk of progression or death.
Dr Pierre Blanchard, a radiation oncologist from the Institut Gustave Roussy, Villejuif, France, will tell the congress that, although concomitant chemoradiation (CRT), where radiotherapy and chemotherapy are delivered together, remains the standard of care for patients with locally advanced head and neck squamous cell carcinomas, AFRT should be considered when treatment intensification is sought-after and CRT is not feasible because of other pre-existing conditions such as cardiac and renal disease.
AFRT is an intensified radiotherapy treatment that can be given in various schedules. The first is hyperfractionation, where radiotherapy is given twice daily ten times per week, resulting in a higher total dose of around 80 Grays (Gy) [2] compared with the dose of 70 Gy given using SFRT in the same overall time (around seven weeks). The second way uses an accelerated schedule, where the overall treatment time is reduced but the dose is kept at the same level or at a lower dose. AFRT is associated with increased acute side-effects but not late side-effects, compared to SFRT.
"After than more than seven years patient follow-up, our research has shown that the higher dose intensity of AFRT works to improve outcomes," says Dr Blanchard. "The hyperfractionated regime is the most effective in terms of overall survival. Indeed, in this group of trials the risk of death is reduced by 18% by the use of hyperfractionated radiotherapy, with 41% of patients alive at five years compared to 33% in the SFRT group. While the acute side-effects of AFRT are increased compared to those experienced by patients on SFRT, the late side-effects are comparable and, overall, side-effects are more than compensated for by the significant increase in survival in the AFRT group."
The meta-analysis was carried out by an international collaboration known as MARCH, including many countries in Europe, the USA, Canada, and Brazil, Egypt and developing countries through the International Atomic Energy Authority. The researchers say that the survival benefits are mostly related to improvements in locoregional control, the area located close to the primary tumour being by far the most common first site of relapse in this disease.
"These data are a major advance for understanding the role in AFRT in head and neck squamous cell carcinoma," says Dr Blanchard. "By carrying out a large-scale analysis such as this one, we believe that we have provided enough evidence to indicate that doctors should recommend AFRT as a validated treatment option for head and neck cancer patients."
Professor Cornelis van de Velde, President of ECCO, said: "This large-scale analysis of patients with head and neck cancer shows that hyperfractionation increases survival, and local control is also improved by the use of this technique. This is an important step forward in the treatment of this devastating disease."
###
[1] The 2013 European Cancer Congress is the 17th congress of the European CanCer Organisation (ECCO), the 38th congress of the European Society for Medical Oncology (ESMO) and the 32nd congress of European Society for Therapeutic Radiology and Oncology (ESTRO).
[2] One Gray is the absorption of one joule of energy, in the form of ionising radiation, per kilogram of matter.
[3] The research was funded by the French Ministry of Health (Programme Hospitalier de Recherche Clinique) and the French Anticancer League (Ligue contre le Cancer).
Hyperfractionated radiotherapy improves survival in head and neck cancer patients
2013-09-28
ELSE PRESS RELEASES FROM THIS DATE:
Researchers demonstrate 'accelerator on a chip'
2013-09-28
In an advance that could dramatically shrink particle accelerators for science and medicine, researchers used a laser to accelerate electrons at a rate 10 times higher than conventional technology in a nanostructured glass chip smaller than a grain of rice.
The achievement was reported today in Nature by a team including scientists from the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory and Stanford University.
"We still have a number of challenges before this technology becomes practical for real-world use, but eventually it would substantially ...
Survival after cancer diagnosis in Europe associated with amount governments spend on health care
2013-09-28
The more an EU (European Union) national government spends on health, the fewer the deaths after a cancer diagnosis in that country, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday) and published simultaneously in the leading cancer journal Annals of Oncology [2].
Researchers will tell the meeting that higher wealth and higher health expenditure are strongly associated both with increased cancer incidence and decreased cancer mortality. In the case of breast cancer, increased health expenditure appears to be ...
Colorectal cancer screening works
2013-09-28
Screening for colorectal cancer (CRC) in European countries is highly effective in reducing mortality from the disease. Some of the resources currently being devoted to breast and prostate screening programmes, where the evidence of effectiveness is much less clear-cut, should be reallocated to the early detection of CRC, the 2013 European Cancer Congress (ECC2013) [1] will hear today (Sunday).
Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France, will report on results extracted from data on CRC ...
Diabetes increases the risk of developing and dying from breast and colon cancer
2013-09-28
Diabetes is linked to an increased risk of developing cancer, and now researchers have performed a unique meta-analysis that excludes all other causes of death and found that diabetic patients not only have an increased risk of developing breast and colon cancer but an even higher risk of dying from them.
Dr Kirstin De Bruijn will tell the 2013 European Cancer Congress (ECC2013) [1], today (Sunday), that previous studies have examined the association between diabetes and dying from cancer but death from specific types of cancer has not been well-studied. "Our meta-analysis ...
Young patients with metastatic colorectal cancer are at high risk of disease progression and death
2013-09-28
Younger patients with colorectal cancer that has spread (metastasised) to other parts of the body represent a high-risk group that is less likely to respond to anti-cancer treatments. Their disease is more likely to progress and they are at greater risk of death than other age groups, according to new research to be presented to the 2013 European Cancer Congress (ECC2013) [1] today (Sunday).
An analysis of 20,034 patients in 24 phase III clinical trials [2] for colorectal cancer, of which 695 patients (3%) were younger than 40, showed that the youngest and oldest patients ...
Everolimus slows disease progression in advanced papillary kidney cancer patients
2013-09-28
The first Phase II study to investigate the use of the anti-cancer drug, everolimus, for the initial treatment of advanced papillary kidney cancer has shown that it is successful in slowing or preventing the spread of the disease, according to research to be presented today (Sunday) at the 2013 European Cancer Congress (ECC2013) [1].
Dr Bernard Escudier, Head of the French Group of Immunotherapy and chairman of the Genitourinary tumour board at the Institut Gustave Roussy in Villejuif, France will say: "Our results showed that for 59% of patients who received everolimus ...
Combining Chinese and Western medicine could lead to new cancer treatments
2013-09-28
Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.
Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine.
The team also set-out to examine how by combining it with more traditional methods like Chemotherapy could improve patient outcomes and potentially lead to the development of new cancer treatments and therapies.
"Traditional ...
Yoga in menopause may help insomnia -- but not hot flashes
2013-09-28
Seattle, WA—Taking a 12-week yoga class and practicing at home was linked to less insomnia—but not to fewer or less bothersome hot flashes or night sweats. The link between yoga and better sleep was the only statistically significant finding in this MsFLASH (Menopause Strategies: Finding Lasting Answers for Symptoms and Health) Network randomized controlled trial.
"Many women suffer from insomnia during menopause, and it's good to know that yoga may help them," said lead author Katherine Newton, PhD, a senior investigator at Group Health Research Institute. She e-published ...
First step to reduce plant need for nitrogen fertilizer uncovered
2013-09-28
COLUMBIA, Mo. — Nitrogen fertilizer costs U.S. farmers approximately $8 billion each year, and excess fertilizer can find its way into rivers and streams, damaging the delicate water systems. Now, a discovery by a team of University of Missouri researchers could be the first step toward helping crops use less nitrogen, benefitting both farmers' bottom lines and the environment. The journal Science published the research this month.
Gary Stacey, an investigator in the MU Bond Life Sciences Center and professor of plant sciences in the College of Agriculture, Food and Natural ...
SUNRISE offers new insight on sun's atmosphere
2013-09-28
Three months after the flight of the solar observatory Sunrise – carried aloft by a NASA scientific balloon in early June 2013 -- scientists from the Max Planck Institute for Solar System Research in Germany have presented unique insights into a layer on the sun called the chromosphere. Sunrise provided the highest-resolution images to date in ultraviolet light of this thin corrugated layer, which lies between the sun's visible surface and the sun's outer atmosphere, the corona.
With its one-meter mirror, Sunrise is the largest solar telescope to fly above the atmosphere. ...